Editorial [Hot Topic: Recent Progress in the Development of Anti-Diabetic Drugs (Guest Editor: J. Eckel)]

By  

Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents, Vol. 5, Iss. 6, 2005-12 ,pp. : 467-467

Bentham Science Publishers

Access to resources Recommend Favorite

Anandamide hydrolysis: a new target for anti-anxiety drugs?

By Gaetani S.   Cuomo V.   Piomelli D.  

Trends in Molecular Medicine, Vol. 9, Iss. 11, 2003-11 ,pp. : 474-478

Elsevier

Access to resources Recommend Favorite

Repurposing of Anti-Diabetic Agents for the Treatment of Cognitive Impairment and Mood Disorders

By  

Current Molecular Medicine, Vol. 16, Iss. 5, 2016-06 ,pp. : 465-473

Bentham Science Publishers

Access to resources Recommend Favorite

A retrospective study on 226 polycythemia vera patients: impact of median hematocrit value on clinical outcomes and survival improvement with anti-thrombotic prophylaxis and non-alkylating drugs

By Crisà Elena   Venturino Ermanno   Passera Roberto   Prina Marco   Schinco Piercarla   Borchiellini Alessandra   Giai Valentina   Ciocca Vasino Maria   Bazzan Mario   Vaccarino Antonella   Boccadoro Mario   Ferrero Dario  

Annals of Hematology, Vol. 89, Iss. 7, 2010-07 ,pp. : 691-699

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of Antidiabetic Activity of Carnosol (Phenolic Diterpene in Rosemary) in Streptozotocin-Induced Diabetic Rats

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 17, Iss. 1, 2017-07 ,pp. : 11-17

Bentham Science Publishers

Access to resources Recommend Favorite